Author + information
- Received April 4, 2020
- Revision received April 13, 2020
- Accepted April 13, 2020
- Published online June 29, 2020.
- Jason N. Katz, MD, MHSa,∗∗ (, )@JasonKatzMD,
- Shashank S. Sinha, MD, MScb,∗@ShashankSinhaMD,
- Carlos L. Alviar, MDc,
- David M. Dudzinski, MD, JDd,
- Ann Gage, MDe,
- Samuel B. Brusca, MDf,
- M. Casey Flanagan, MDb,
- Timothy Welch, MDb,g,
- Bram J. Geller, MDh,
- P. Elliott Miller, MDi,
- Sergio Leonardi, MD, MHSj,
- Erin A. Bohula, MD, DPhilk,
- Susanna Price, MD, PhDl,
- Sunit-Preet Chaudhry, MDm,
- Thomas S. Metkus, MDn,
- Connor G. O’Brien, MDo,
- Alessandro Sionis, MDp,
- Christopher F. Barnett, MDq,
- Jacob C. Jentzer, MDr,
- Michael A. Solomon, MDf,s,
- David A. Morrow, MD, MPHk and
- Sean van Diepen, MD, MSct@seanvandiepen
- aDivision of Cardiology, Duke University, Durham, North Carolina
- bInova Heart and Vascular Institute, Inova Fairfax Medical Center, Falls Church, Virginia
- cLeon H. Charney Division of Cardiology, New York University Langone Medical Center NYU Langone Medical Center, New York, New York
- dDivision of Cardiology, Massachusetts General Hospital, Boston, Massachusetts
- eDivision of Cardiology, Cleveland Clinic, Cleveland, Ohio
- fCritical Care Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland
- gVirginia Heart, Falls Church, Virginia
- hDivision of Cardiology, Maine Medical Center, Portland, Maine
- iSection of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut
- jCoronary Care Unit and Laboratory of Clinical and Experimental Cardiology-Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy
- kTIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
- lRoyal Brompton and Harefield NHS Foundation Trust, Royal Brompton Hospital, London, United Kingdom
- mDepartment of Cardiology, St. Vincent Hospital, Indianapolis, Indiana
- nDivision of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland
- oDivision of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, California
- pIntensive Cardiac Care Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute IIB-SantPaul, Universidad Autonoma de Barcelona, Barcelona, Spain
- qDepartment of Cardiology, Medstar Washington Hospital Center, Washington, DC
- rDepartment of Cardiovascular Medicine and Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota
- sCardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
- tDepartment of Critical Care and Division of Cardiology, Department of Medicine, University of Alberta Hospital, Alberta, Canada
- ↵∗Address for correspondence:
Dr. Jason N. Katz, 2301 Erwin Road, DUMC Box 3126, Durham, North Carolina 27710.
• Acute complications of COVID-19 can result in severe perturbations of the respiratory, cardiovascular, and immune systems.
• Critical care cardiologists may be uniquely positioned to develop and disseminate novel solutions to meet patient and workforce demands.
• Many opportunities exist to develop scalable models of critical care delivery and effective research collaboration.
The COVID-19 pandemic has presented a major unanticipated stress on the workforce, organizational structure, systems of care, and critical resource supplies. To ensure provider safety, to maximize efficiency, and to optimize patient outcomes, health systems need to be agile. Critical care cardiologists may be uniquely positioned to treat the numerous respiratory and cardiovascular complications of the SARS-CoV-2 and support clinicians without critical care training who may be suddenly asked to care for critically ill patients. This review draws upon the experiences of colleagues from heavily impacted regions of the United States and Europe, as well as lessons learned from military mass casualty medicine. This review offers pragmatic suggestions on how to implement scalable models for critical care delivery, cultivate educational tools for team training, and embrace technologies (e.g., telemedicine) to enable effective collaboration despite social distancing imperatives.
↵∗ Drs. Katz and Sinha are co-first authors.
Drs. Brusca and Solomon receive research support from the National Institutes of Health Clinical Center intramural research fund.
Dr. Metkus has been a consultant for BestDoctors Inc. and Oakstone/EBIX; and has received royalties for a textbook from McGraw-Hill. Dr. Sionis has received consulting fees from Sanofi. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page.
- Received April 4, 2020.
- Revision received April 13, 2020.
- Accepted April 13, 2020.
- 2020 American College of Cardiology Foundation
- Central Illustration
- Epidemiology of COVID-19 and Its Cardiovascular Manifestations
- Potential Workforce Adaptations to Meet Evolving Pandemic Demands
- Lessons Learned from Military Medicine and its Application During the COVID-19 Pandemic
- A Practical Blueprint to Enhance Education and Collaboration